Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation.

Xing Y, Lin NU, Maurer MA, Chen H, Mahvash A, Sahin A, Akcakanat A, Li Y, Abramson V, Litton J, Chavez-MacGregor M, Valero V, Piha-Paul SA, Hong D, Do KA, Tarco E, Riall D, Eterovic AK, Wulf GM, Cantley LC, Mills GB, Doyle LA, Winer E, Hortobagyi GN, Gonzalez-Angulo AM, Meric-Bernstam F.

Breast Cancer Res. 2019 Jul 5;21(1):78. doi: 10.1186/s13058-019-1154-8.

2.

Calculation of lung mean dose and quantification of error for 90 Y-microsphere radioembolization using 99m Tc-MAA SPECT/CT and diagnostic chest CT.

Lopez B, Mahvash A, Lam MGEH, Kappadath SC.

Med Phys. 2019 May 7. doi: 10.1002/mp.13575. [Epub ahead of print]

PMID:
31063600
3.

Preoperative drainage for perihilar cholangiocarcinoma.

Odisio BC, Krampitz GW, Murthy R, Mahvash A, Javle M, Vauthey JN.

Lancet Gastroenterol Hepatol. 2019 Jan;4(1):10-11. doi: 10.1016/S2468-1253(18)30345-5. Epub 2018 Dec 6. No abstract available.

PMID:
30527574
4.

Hepatocellular Carcinoma Tumor Dose Response After 90Y-radioembolization With Glass Microspheres Using 90Y-SPECT/CT-Based Voxel Dosimetry.

Kappadath SC, Mikell J, Balagopal A, Baladandayuthapani V, Kaseb A, Mahvash A.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):451-461. doi: 10.1016/j.ijrobp.2018.05.062. Epub 2018 Jun 2.

PMID:
30191875
5.

Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular Carcinoma.

Niekamp A, Abdel-Wahab R, Kuban J, Odisio BC, Mahvash A, Hassan MM, Qayyum A, Kaseb A, Sheth RA.

J Clin Med. 2018 Apr 14;7(4). pii: E83. doi: 10.3390/jcm7040083.

6.

Portomesenteric Venous Stenting for Palliation of Ascites and Variceal Bleeding Caused by Prehepatic Portal Hypertension.

Sheth RA, Sabir SH, Parmet P, Amin R, Kuban JD, Huang SY, Mahvash A, Fogelman D, Javle M, Wallace MJ.

Oncologist. 2018 Jun;23(6):712-718. doi: 10.1634/theoncologist.2017-0337. Epub 2017 Dec 28.

7.

Adequate SIRT activity dose is as important as adequate chemotherapy dose.

Braat AJAT, Kappadath SC, Bruijnen RCG, van den Hoven AF, Mahvash A, de Jong HWAM, Lam MGEH.

Lancet Oncol. 2017 Nov;18(11):e636. doi: 10.1016/S1470-2045(17)30811-2. Epub 2017 Oct 31. No abstract available.

PMID:
29208390
8.

Impact of an inferior vena cava filter retrieval algorithm on filter retrieval rates in a cancer population.

Litwin RJ, Huang SY, Sabir SH, Hoang QB, Ahrar K, Ahrar J, Tam AL, Mahvash A, Ensor JE, Kroll M, Gupta S.

J Vasc Surg Venous Lymphat Disord. 2017 Sep;5(5):689-697. doi: 10.1016/j.jvsv.2017.05.017.

PMID:
28818223
9.

Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States.

Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO.

Oncology. 2017;93(4):233-242. doi: 10.1159/000455957. Epub 2017 Jul 6.

PMID:
28683459
10.

Prognostic value of incidental hypervascular micronodules detected on cone-beam computed tomography angiography of patients with liver metastasis.

Odisio BC, Cox VL, Faria SC, Yamashita S, Shi X, Ensor J, Jones AK, Mahvash A, Gupta S, Tam AL, Vauthey JN, Murthy R.

Eur Radiol. 2017 Nov;27(11):4837-4845. doi: 10.1007/s00330-017-4847-3. Epub 2017 May 8.

PMID:
28484824
11.

Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.

Morris VK, Salem ME, Nimeiri H, Iqbal S, Singh P, Ciombor K, Polite B, Deming D, Chan E, Wade JL, Xiao L, Bekaii-Saab T, Vence L, Blando J, Mahvash A, Foo WC, Ohaji C, Pasia M, Bland G, Ohinata A, Rogers J, Mehdizadeh A, Banks K, Lanman R, Wolff RA, Streicher H, Allison J, Sharma P, Eng C.

Lancet Oncol. 2017 Apr;18(4):446-453. doi: 10.1016/S1470-2045(17)30104-3. Epub 2017 Feb 18.

12.

Efficacy of a Self-expanding Tract Sealant Device in the Reduction of Pneumothorax and Chest Tube Placement Rates After Percutaneous Lung Biopsy: A Matched Controlled Study Using Propensity Score Analysis.

Ahrar JU, Gupta S, Ensor JE, Mahvash A, Sabir SH, Steele JR, McRae SE, Avritscher R, Huang SY, Odisio BC, Murthy R, Ahrar K, Wallace MJ, Tam AL.

Cardiovasc Intervent Radiol. 2017 Feb;40(2):270-276. doi: 10.1007/s00270-016-1489-9. Epub 2016 Nov 8.

13.

Selective Internal Radiation Therapy With Yttrium-90 Glass Microspheres: Biases and Uncertainties in Absorbed Dose Calculations Between Clinical Dosimetry Models.

Mikell JK, Mahvash A, Siman W, Baladandayuthapani V, Mourtada F, Kappadath SC.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):888-896. doi: 10.1016/j.ijrobp.2016.07.021. Epub 2016 Jul 27.

14.

Minimally invasive image-guided therapies for hepatocellular carcinoma.

Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC.

J Hepatocell Carcinoma. 2016 Oct 11;3:55-61. eCollection 2016. Review.

15.

Multiple Renal Artery Pseudoaneurysms in Patients Undergoing Renal Artery Embolization Following Partial Nephrectomy: Correlation with RENAL Nephrometry Scores.

Gupta N, Patel A, Ensor J, Ahrar K, Ahrar J, Tam A, Odisio B, Huang S, Murthy R, Mahvash A, Avritscher R, McRae S, Sabir S, Wallace M, Matin S, Gupta S.

Cardiovasc Intervent Radiol. 2017 Feb;40(2):202-209. doi: 10.1007/s00270-016-1473-4. Epub 2016 Sep 28.

PMID:
27681271
16.

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma.

Mahvash A, Murthy R, Odisio BC, Raghav KP, Girard L, Cheung S, Nguyen V, Ensor J, Gadani S, Elsayes KM, Abdel-Wahab R, Hassan M, Shalaby AS, Yao JC, Wallace MJ, Kaseb AO.

J Hepatocell Carcinoma. 2016 Feb 5;3:1-7. doi: 10.2147/JHC.S62261. eCollection 2016.

17.

Balloon-Assisted Flow Diversion and Selective Catheterization of Target Vessels for Hepatic Transarterial Embolization.

Abdelsalam ME, Mahvash A, Avritscher R, McRae SE, Odisio BC.

J Vasc Interv Radiol. 2016 Feb;27(2):283-5. doi: 10.1016/j.jvir.2015.10.022. No abstract available.

PMID:
26830942
18.

Eradication of Missing Liver Metastases After Fiducial Placement.

Passot G, Odisio BC, Zorzi D, Mahvash A, Gupta S, Wallace MJ, Kim BJ, Yamashita S, Conrad C, Aloia TA, Vauthey JN, Chun YS.

J Gastrointest Surg. 2016 Jun;20(6):1173-8. doi: 10.1007/s11605-016-3079-1. Epub 2016 Jan 20.

PMID:
26791387
19.

Comparing voxel-based absorbed dosimetry methods in tumors, liver, lung, and at the liver-lung interface for (90)Y microsphere selective internal radiation therapy.

Mikell JK, Mahvash A, Siman W, Mourtada F, Kappadath SC.

EJNMMI Phys. 2015 Dec;2(1):16. doi: 10.1186/s40658-015-0119-y. Epub 2015 Jul 30.

20.

The Effect of Needle Gauge on the Risk of Pneumothorax and Chest Tube Placement After Percutaneous Computed Tomographic (CT)-Guided Lung Biopsy.

Kuban JD, Tam AL, Huang SY, Ensor JE, Philip AS, Chen GJ, Ahrar J, Murthy R, Avritscher R, Madoff DC, Mahvash A, Ahrar K, Wallace MJ, Nachiappan AC, Gupta S.

Cardiovasc Intervent Radiol. 2015 Dec;38(6):1595-602. doi: 10.1007/s00270-015-1097-0. Epub 2015 Apr 30.

PMID:
25920917

Supplemental Content

Loading ...
Support Center